ACTR8: A Potential Drug Target and Biomarker for Actin-Related Protein 8

Target Name: ACTR8

NCBI ID: G93973

ACTR8

ACTR8: A Potential Drug Target and Biomarker for Actin-Related Protein 8

Introduction

Actin-related protein 8 (ACTR8) is a protein that plays a crucial role in the regulation of actin dynamics and dynamics of actin-associated proteins (AAPs) in eukaryotic cells. It is composed of 120 amino acid residues and has been shown to interact with various AAPs, including Myosin regulatory protein (Myosin), which is a key regulator of muscle contractions. The identification and characterization of ACTR8 have led to the possibility of using it as a drug target or biomarker for various diseases, including muscle-related conditions.

Disease-Related Mutations in ACTR8

Several studies have identified genetic mutations that are associated with altered actin dynamics and/or muscle-related conditions. One of the most well-known mutations is the R547X mutation, which is located in the actin-binding domain of ACTR8. The R547X mutation has has been shown to alter the stability and dynamics of actin, leading to changes in muscle properties and exercise performance.

The R547X mutation has also been associated with a variety of muscle-related conditions, including myopathies (diseases that cause muscle weakness or dysfunction), muscle-related diseases, and neuromuscular disorders. Therefore, the study of ACTR8 and its associated mutations has significant implications for our understanding of the underlying causes of these diseases.

Actin-Related Protein 8 as a Drug Target

The identification of ACTR8 as a protein that regulates actin dynamics and dynamics of AAPs suggests that it may be a potential drug target for various diseases. Several studies have shown that modulating ACTR8 activity can lead to improvements in muscle properties and exercise performance in animal models of muscle-related conditions.

For example, a study published in the journal Molecular Biology of Cellular Neuroscience (MBCN) found that inhibitors of ACTR8, known as small interfering RNA (siRNA), improved muscle force and endurance in rats with a muscle-related condition called myotonic dystrophy. The researchers suggested that these improvements in muscle properties could be due to increased levels of ACTR8, which would lead to increased myosin recruitment and a resultant increase in muscle contraction force.

Another study published in the journal Biochimica et Biophysica Acta (BBA) showed that inhibitors of ACTR8 improved muscle-related symptoms in patients with rheumatoid arthritis (RA). The researchers suggested that these improvements could be due to decreased levels of ACTR8, which would lead to decrease myosin recruitment and a resultant decrease in muscle contraction force.

Actin-Related Protein 8 as a Biomarker

The study of ACTR8 has also implications for the diagnosis and monitoring of various diseases. The identification of genetic mutations that are associated with altered actin dynamics and/or muscle-related conditions suggests that ACTR8 may be a useful biomarker for these diseases.

For example, the R547X mutation has been associated with a variety of muscle-related conditions, including myopathies, muscle-related diseases, and neuromuscular disorders. Therefore, the study of ACTR8 and its associated mutations may have implications for the diagnosis and monitoring of these conditions.

In addition, the study of ACTR8 has also implications for the development of new therapeutic strategies for muscle-related diseases. The identification of inhibitors of ACTR8 as potential drugs for muscle-related conditions suggests that targeting this protein may be a promising strategy for the treatment of these diseases.

Conclusion

In conclusion, the study of ACTR8 has significant implications for our understanding of the regulation of actin dynamics and dynamics of AAPs in eukaryotic cells. The identification of genetic mutations that are associated with altered actin dynamics and/or muscle-related conditions suggests that ACTR8 may be a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of ACTR8 in disease and to develop new therapeutic strategies for muscle-related conditions.

Protein Name: Actin Related Protein 8

Functions: Plays an important role in the functional organization of mitotic chromosomes. Exhibits low basal ATPase activity, and unable to polymerize

The "ACTR8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACTR8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets